These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3410736)

  • 1. High-dose intravenous immunoglobulin for myasthenia gravis.
    Sakano T; Hamasaki T; Shimizu H; Harada Y; Ueda K
    Hiroshima J Med Sci; 1988 Mar; 37(1):7-9. PubMed ID: 3410736
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment for refractory myasthenia gravis.
    Sakano T; Hamasaki T; Kinoshita Y; Kihara M; Ueda K
    Arch Dis Child; 1989 Aug; 64(8):1191-3. PubMed ID: 2782938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent developments in high-dose immunoglobulin therapy: therapeutic plasma exchange, autoimmune diseases].
    Kalden JR; Schranz W; Lösch G; Krapf F; Bartels O
    Beitr Infusionther Klin Ernahr; 1982; 9():48-59. PubMed ID: 6216881
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose intravenous immunoglobulin in the management of myasthenia gravis.
    Bonaventura I; Ponseti J; Arnau E; Matias-Guiu J; Codina Puiggros A
    Arch Intern Med; 1987 Feb; 147(2):207, 211. PubMed ID: 3813729
    [No Abstract]   [Full Text] [Related]  

  • 5. Treating ocular Myasthenia Gravis with inadequate evidence.
    Roach ES
    Arch Neurol; 2007 Dec; 64(12):1794-5. PubMed ID: 18071049
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma C3c changes in myasthenia gravis patients receiving high-dose intravenous immunoglobulin during crisis.
    Kamolvarin N; Hemachudha T; Ongpipattanakul B; Phanuphak P; Viddayakorn P; Sueblinvong T
    Acta Neurol Scand; 1989 Oct; 80(4):324-6. PubMed ID: 2816289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular Myasthenia Gravis treatment: the case against prednisone therapy and thymectomy.
    Gilbert ME; De Sousa EA; Savino PJ
    Arch Neurol; 2007 Dec; 64(12):1790-2. PubMed ID: 18071047
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppressive or surgical treatment for ocular Myasthenia Gravis.
    Chavis PS; Stickler DE; Walker A
    Arch Neurol; 2007 Dec; 64(12):1792-4. PubMed ID: 18071048
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous gamma-globulin for chronic inflammatory demyelinating polyneuropathy and myasthenia gravis.
    Keesey JC
    West J Med; 1991 Jul; 155(1):69. PubMed ID: 1715107
    [No Abstract]   [Full Text] [Related]  

  • 10. Experience with programmed steroid treatment with thymectomy in nonthymomatous myasthenia gravis.
    Endo S; Yamaguchi T; Saito N; Otani S; Hasegawa T; Sato Y; Sohara Y
    Ann Thorac Surg; 2004 May; 77(5):1745-50. PubMed ID: 15111178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose intravenous immunoglobulin G treatment of myasthenia gravis.
    Ferrero B; Durelli L
    Neurol Sci; 2002 Apr; 23 Suppl 1():S9-24. PubMed ID: 12032583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term treatment with 7S immunoglobulins in myasthenia gravis. Preliminary clinical results].
    Bamberg C; Janzen RW; Szabados M
    Nervenarzt; 1996 Apr; 67(4):327-32. PubMed ID: 8684513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombocytic diseases in generalized myasthenia gravis and their correction by using plasmapheresis and administration of anti- immunoglobulin antisera].
    Shimkevich LL; Rudneva VG; Sapin SM; Marchuk AI; Golovteev VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(11):47-50. PubMed ID: 2624050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose intravenous immunoglobulin in myasthenia gravis.
    Evoli A; Palmisani MT; Bartoccioni E; Padua L; Tonali P
    Ital J Neurol Sci; 1993 Apr; 14(3):233-7. PubMed ID: 8314677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose intravenous gammaglobulin for myasthenia gravis.
    Fateh-Moghadam A; Wick M; Besinger U; Geursen RG
    Lancet; 1984 Apr; 1(8381):848-9. PubMed ID: 6200741
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-dose tacrolimus for two cases of myasthenia gravis with invasive thymoma that relapsed shortly after thymectomy.
    Tsukaguchi M; Shimamura M; Ikeda K; Urai Y; Sasaki I; Deguchi K; Touge T; Takeuchi H; Kuriyama S
    J Neurol Sci; 2005 Apr; 231(1-2):85-8. PubMed ID: 15792826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis: effect of immunoactive therapies.
    Fornádi L; Horváth R; Bárdosi Z; Szobor A
    Acta Med Hung; 1994; 50(1-2):83-92. PubMed ID: 7638045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does perioperative high-dose prednisolone have clinical benefits for generalized myasthenia gravis?
    Sekine Y; Kawaguchi N; Hamada C; Sekiguchi H; Yasufuku K; Iyoda A; Shibuya K; Fujisawa T
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):908-13. PubMed ID: 16675232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis.
    Jensen P; Bril V
    J Clin Neuromuscul Dis; 2008 Mar; 9(3):352-5. PubMed ID: 18344718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of intractable myasthenia gravis treated with cyclosporine and high-dose intravenous immunoglobulin].
    Sato A; Katsui T; Honma A; Koike R; Tanaka M; Tanaka K; Tsuji S
    Nihon Naika Gakkai Zasshi; 1996 Feb; 85(2):279-81. PubMed ID: 8708459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.